Hudock, Inc. Eli Lilly & CO Transaction History

Hudock, Inc.

$578 Million
Q3 2024

A detailed history of Hudock, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Hudock, Inc. holds 2,797 shares of LLY stock, worth $2.23 Million. This represents 0.43% of its overall portfolio holdings.

Number of Shares

2,797

Previous 2,774 0.83%

Holding current value

$2.23 Million

Previous $2.51 Million 1.35%

% of portfolio

0.43%

Previous 0.47%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	BUY	$772.14 - $960.02 $17,759 - $22,080	23 Added 0.83%	2,797 $2.48 Million
Q2 2024 Aug 02, 2024	SELL	$724.87 - $909.04 $79,010 - $99,085	-109 Reduced 3.78%	2,774 $2.51 Million
Q1 2024 May 02, 2024	SELL	$592.2 - $792.28 $13,028 - $17,430	-22 Reduced 0.76%	2,883 $2.24 Million
Q4 2023 Jan 22, 2024	SELL	$525.19 - $619.13 $20,482 - $24,146	-39 Reduced 1.32%	2,905 $1.69 Million
Q3 2023 Nov 06, 2023	BUY	$434.7 - $599.3 $43,470 - $59,929	100 Added 3.52%	2,944 $1.58 Million
Q2 2023 Jul 31, 2023	BUY	$350.74 - $468.98 $556,624 - $744,271	1,587 Added 126.25%	2,844 $1.33 Million
Q1 2023 May 08, 2023	BUY	$310.63 - $364.82 $21,744 - $25,537	70 Added 5.9%	1,257 $431,000
Q4 2022 Feb 08, 2023	BUY	$321.55 - $374.67 $321 - $374	1 Added 0.08%	1,187 $434,000
Q3 2022 Nov 02, 2022	BUY	$296.48 - $337.87 $86,572 - $98,658	292 Added 32.66%	1,186 $383,000
Q2 2022 Aug 02, 2022	BUY	$278.73 - $327.27 $1,393 - $1,636	5 Added 0.56%	894 $289,000
Q1 2022 May 02, 2022	SELL	$234.69 - $291.66 $149,966 - $186,370	-639 Reduced 41.82%	889 $254,000
Q4 2021 Jan 19, 2022	BUY	$224.85 - $279.04 $674 - $837	3 Added 0.2%	1,528 $422,000
Q3 2021 Nov 09, 2021	SELL	$221.6 - $272.71 $50,524 - $62,177	-228 Reduced 13.01%	1,525 $352,000
Q2 2021 Aug 09, 2021	BUY	$180.55 - $233.54 $722 - $934	4 Added 0.23%	1,753 $402,000
Q1 2021 Apr 26, 2021	BUY	$164.32 - $212.72 $657 - $850	4 Added 0.23%	1,749 $326,000
Q4 2020 Feb 05, 2021	BUY	$130.46 - $172.63 $101,758 - $134,651	780 Added 80.83%	1,745 $294,000
Q2 2020 Aug 11, 2020	BUY	$136.42 - $164.18 $3,546 - $4,268	26 Added 2.77%	965 $158,000
Q1 2020 Apr 27, 2020	BUY	$119.05 - $147.35 $119 - $147	1 Added 0.11%	939 $130,000
Q3 2019 Oct 31, 2019	BUY	$106.79 - $116.16 $5,446 - $5,924	51 Added 5.75%	938 $104,000
Q2 2019 Jul 30, 2019	SELL	$110.79 - $129.32 $35,009 - $40,865	-316 Reduced 26.27%	887 $98,000
Q1 2019 Apr 23, 2019	BUY	$111.31 - $131.02 $35,396 - $41,664	318 Added 35.93%	1,203 $156,000
Q2 2018 Aug 01, 2018	BUY	$75.7 - $86.88 $10,219 - $11,728	135 Added 18.0%	885 $75,000
Q2 2017 Aug 08, 2017	BUY	N/A	750	750 $61,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hudock, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hudock, Inc. with notifications on news.

Account